A doctor and a patient discussing a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation ...

After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

A scientist working in Switzerland has become the fifth person to be convicted of attempting to steal trade secrets from pharmaceutical ... attempted to re-brand GSK products under development ...

Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.

The company reported strong performance across key product portfolios ... In the vaccines segment, GlaxoSmithKline Pharmaceuticals maintained leadership in the self-pay private market for ...

The quarter saw strong performance across key product portfolios ... Managing Director of GlaxoSmithKline Pharmaceuticals Limited, said, “Our strong third-quarter results reflect our unwavering ...

The company anticipates five new product approvals in 2025 ... sales target to over £40 billion. Overall GSK ranks 5th on our list of the cheap pharmaceutical stocks to buy according to analysts.